By: Heather Blumenthal Immunotherapy is enormously promising for cancer treatment. But while every day research is every day advancing the area, thanks in part to funding from BioCanRx, it is expensive – and that expense pales in comparison to the cost of bringing a discovery out of the lab and into human trials and… Read more »
